Skorpios Trust, Former 10% owner at Akero Therapeutics, holds 10.84M shares in Stoke Therapeutics (Ticker: STOK), holds 3.27M shares in Akero Therapeutics (Ticker: AKRO). Most recently, Skorpios Trust Sold ― shares of Stoke Therapeutics on Apr 18, 2024 for an estimated value of 41.76M.